L. Bassler Bonnie's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 1,064 Class A Ordinary Shares done at an average price of $35.2 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 35.24 per share. | 30 Jun 2025 | 1,064 | 71,118 | - | 35.2 | 37,495 | Class A Ordinary Shares |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 11,100 | 11,100 | - | - | Stock Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 7,614 | 70,054 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 32.87 per share. | 31 Mar 2025 | 1,141 | 62,440 | - | 32.9 | 37,500 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,958 | 1,958 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 166 | 1,548 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 24.94 per share. | 31 Dec 2024 | 1,503 | 61,299 | - | 24.9 | 37,487 | Class A Ordinary Shares |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 27.92 per share. | 30 Sep 2024 | 1,342 | 59,796 | - | 27.9 | 37,475 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 371.40 per share. | 15 Aug 2024 | 756 | 2,138 (0%) | 0% | 371.4 | 280,778 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 756 | 1,516 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 1170.00 per share. | 15 Aug 2024 | 756 | 1,382 (0%) | 0% | 1170 | 884,520 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 756 | 2,272 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 371.40 per share. | 02 Aug 2024 | 756 | 2,138 (0%) | 0% | 371.4 | 280,778 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 1115.00 per share. | 02 Aug 2024 | 756 | 1,382 (0%) | 0% | 1115 | 842,940 | Common Stock |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 2,125 | 2,125 | - | - | Stock Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 26.80 per share. | 28 Jun 2024 | 1,399 | 58,454 | - | 26.8 | 37,493 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 1062.00 per share. | 24 Jun 2024 | 756 | 1,382 (0%) | 0% | 1062 | 802,872 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 756 | 3,028 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 371.40 per share. | 24 Jun 2024 | 756 | 2,138 (0%) | 0% | 371.4 | 280,778 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,293 | 57,055 | - | 0 | Class A Ordinary Shares | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 827 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 1011.00 per share. | 05 Jun 2024 | 827 | 1,382 (0%) | 0% | 1011 | 836,097 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 05 Jun 2024 | 827 | 2,209 (0%) | 0% | 381.0 | 315,046 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 30.23 per share. | 28 Mar 2024 | 1,240 | 47,762 | - | 30.2 | 37,483 | Class A Ordinary Shares |
| Regeneron Pharma | Bassler L. Bonnie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 26 Feb 2024 | 854 | 2,236 (0%) | 0% | 391.9 | 334,700 | Common Stock |
| Regeneron Pharma | L. Bassler Bonnie | Director | Sale of securities on an exchange or to another person at price $ 979.25 per share. | 26 Feb 2024 | 854 | 1,382 (0%) | 0% | 979.3 | 836,280 | Common Stock |
| Regeneron Pharma | L. Bassler Bonnie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 854 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 30 Jan 2024 | 827 | 2,209 (0%) | 0% | 381.0 | 315,046 | Common Stock |
| Regeneron Pharma | L. Bonnie Bassler | Director | Sale of securities on an exchange or to another person at price $ 959.00 per share. | 30 Jan 2024 | 827 | 1,382 (0%) | 0% | 959 | 793,093 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2024 | 827 | 827 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | L. Bassler Bonnie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,607 | 1,607 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bassler L. Bonnie | Director | Sale of securities on an exchange or to another person at price $ 914.00 per share. | 02 Jan 2024 | 826 | 1,382 (0%) | 0% | 914 | 754,964 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 02 Jan 2024 | 826 | 2,208 (0%) | 0% | 381.0 | 314,665 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 826 | 1,654 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bassler L. Bonnie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 135 | 1,382 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | L. Bonnie Bassler | Director | Grant, award, or other acquisition of securities at price $ 27.71 per share. | 29 Dec 2023 | 1,353 | 46,522 | - | 27.7 | 37,493 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie Bassler L. | Director | Sale of securities on an exchange or to another person at price $ 870.00 per share. | 13 Dec 2023 | 610 | 1,247 (0%) | 0% | 870 | 530,700 | Common Stock |
| Regeneron Pharma | L. Bassler Bonnie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 610 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 376.69 per share. | 13 Dec 2023 | 610 | 1,857 (0%) | 0% | 376.7 | 229,781 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2023 | 853 | 854 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 829.00 per share. | 21 Aug 2023 | 853 | 1,247 (0%) | 0% | 829 | 707,137 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 21 Aug 2023 | 853 | 2,100 (0%) | 0% | 391.9 | 334,308 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 10 Aug 2023 | 853 | 2,100 (0%) | 0% | 391.9 | 334,308 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 853 | 1,707 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 789.00 per share. | 10 Aug 2023 | 853 | 1,247 (0%) | 0% | 789 | 673,017 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 31.03 per share. | 30 Jun 2023 | 1,208 | 43,785 | - | 31.0 | 37,481 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,747 | 42,577 | - | 0 | Class A Ordinary Shares | |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 42,500 | 42,500 | - | - | Stock Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 35.73 per share. | 31 Mar 2023 | 1,049 | 34,830 | - | 35.7 | 37,478 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2023 | 1,240 | 2,480 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 24 Mar 2023 | 1,240 | 2,487 (0%) | 0% | 381.0 | 472,378 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 818.00 per share. | 24 Mar 2023 | 1,240 | 1,247 (0%) | 0% | 818 | 1,014,320 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 03 Feb 2023 | 1,021 | 2,268 (0%) | 0% | 381.0 | 388,950 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,021 | 3,720 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 779.00 per share. | 03 Feb 2023 | 1,021 | 1,247 (0%) | 0% | 779 | 795,359 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,929 | 1,929 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 165 | 1,247 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 39.76 per share. | 30 Dec 2022 | 943 | 33,781 | - | 39.8 | 37,495 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 779.00 per share. | 08 Dec 2022 | 218 | 1,082 (0%) | 0% | 779 | 169,822 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 218 | 4,741 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 08 Dec 2022 | 218 | 1,300 (0%) | 0% | 380.9 | 83,047 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 41.06 per share. | 30 Sep 2022 | 913 | 32,838 | - | 41.1 | 37,490 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 08 Sep 2022 | 1,279 | 2,361 (0%) | 0% | 391.9 | 501,266 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 1,279 | 2,560 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 1,279 | 3,839 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 686.99 per share. | 08 Sep 2022 | 1,279 | 1,082 (0%) | 0% | 687.0 | 878,660 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 08 Sep 2022 | 1,279 | 2,361 (0%) | 0% | 391.9 | 501,266 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 705.00 per share. | 08 Sep 2022 | 1,279 | 1,082 (0%) | 0% | 705 | 901,695 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 609 | 610 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 741.00 per share. | 08 Sep 2022 | 609 | 1,082 (0%) | 0% | 741 | 451,269 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 376.69 per share. | 08 Sep 2022 | 609 | 1,691 (0%) | 0% | 376.7 | 229,404 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 41.52 per share. | 30 Jun 2022 | 903 | 31,925 | - | 41.5 | 37,493 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,328 | 31,022 | - | 0 | Class A Ordinary Shares | |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 07 Apr 2022 | 1,240 | 2,322 (0%) | 0% | 381.0 | 472,378 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2022 | 1,240 | 4,959 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 725.00 per share. | 07 Apr 2022 | 1,240 | 1,082 (0%) | 0% | 725 | 899,000 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 38.87 per share. | 31 Mar 2022 | 964 | 24,694 | - | 38.9 | 37,471 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 700.00 per share. | 30 Mar 2022 | 1,240 | 1,082 (0%) | 0% | 700 | 868,000 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2022 | 1,240 | 6,199 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 380.95 per share. | 30 Mar 2022 | 1,240 | 2,322 (0%) | 0% | 381.0 | 472,378 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,707 | 2,707 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 191 | 1,082 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 37.80 per share. | 30 Sep 2021 | 992 | 22,772 | - | 37.8 | 37,499 | Class A Ordinary Shares |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 376.69 per share. | 16 Aug 2021 | 1,219 | 2,110 (0%) | 0% | 376.7 | 459,185 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 1,219 | 1,219 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 630.00 per share. | 16 Aug 2021 | 1,219 | 891 (0%) | 0% | 630 | 767,970 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 05 Aug 2021 | 2,559 | 3,450 (0%) | 0% | 391.9 | 1,002,923 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 2,559 | 5,118 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 600.00 per share. | 05 Aug 2021 | 2,559 | 891 (0%) | 0% | 600 | 1,535,400 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 2,558 | 7,677 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Sale of securities on an exchange or to another person at price $ 575.00 per share. | 01 Jul 2021 | 2,558 | 891 (0%) | 0% | 575 | 1,470,850 | Common Stock |
| Regeneron Pharma | Bonnie L. Bassler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 391.92 per share. | 01 Jul 2021 | 2,558 | 3,449 (0%) | 0% | 391.9 | 1,002,531 | Common Stock |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 43.04 per share. | 30 Jun 2021 | 871 | 21,780 | - | 43.0 | 37,489 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 5,726 | 20,909 | - | 0 | Class A Ordinary Shares | |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 45.90 per share. | 31 Mar 2021 | 816 | 15,183 | - | 45.9 | 37,458 | Class A Ordinary Shares |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 3,613 | 3,613 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 248 | 891 (0%) | 0% | 0 | Common Stock |